HCPCS Q2053 at Legacy Salmon Creek Medical Center
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
What Legacy Salmon Creek Medical Center publishes for this code: as an outpatient
| Who pays | Hospital’s fee (lowest – highest) | Doctor’s fee the hospital lists |
|---|---|---|
| Commercial insurance | $770,655 – $1,101,148 | — |
| Medicare Advantage | $503,969 – $548,005 | — |
| Cash price | — | — |
| List price | — | — |
Bills to expect
The hospital’s fee is the price above. Doctors usually send their own bills. Their amounts here are what original Medicare allows in the rest of Washington for 2026, and a private-plan estimate of 118% to 179% of that (the range found across studies of what insurers pay doctors). Those are estimates, not quotes.
| Bill | What it’s for | Original Medicare allows | Private plan estimate |
|---|---|---|---|
| Hospital's fee | The drug, per billing unit | — | The price above |
Compare HCPCS Q2053 at every Washington hospital, with Medicare’s reference amounts.